The ratio between different subgroups of T-cells thus provides an informative measure for tumor occurrence and progression, for example, the CD8+/CD4+ and CD8+/FOXP3+ ratios are the most-used measurement for the potency of anti-tumor immune activity [36]. This evidence concerns the gene CD8A and neoplasm.